BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 19088256)

  • 1. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.
    Ignatova ID; Kostadinova RM; Goldring CE; Nawrocki AR; Frey FJ; Frey BM
    Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E367-77. PubMed ID: 19088256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of glucocorticoid receptor and CCAAT/enhancer-binding protein alpha in the feed-forward induction of 11beta-hydroxysteroid dehydrogenase type 1 expression by cortisol in human amnion fibroblasts.
    Yang Z; Guo C; Zhu P; Li W; Myatt L; Sun K
    J Endocrinol; 2007 Nov; 195(2):241-53. PubMed ID: 17951535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCAAT/enhancer-binding proteins (C/EBPs) regulate the basal and cAMP-induced transcription of the human 11beta-hydroxysteroid dehydrogenase encoding gene in adipose cells.
    Gout J; Tirard J; Thévenon C; Riou JP; Bégeot M; Naville D
    Biochimie; 2006 Sep; 88(9):1115-24. PubMed ID: 16837116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue.
    Apostolova G; Schweizer RA; Balazs Z; Kostadinova RM; Odermatt A
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E957-64. PubMed ID: 15613680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor alpha and phorbol 12-myristate-13-acetate down-regulate human 11beta-hydroxysteroid dehydrogenase type 2 through p50/p50 NF-kappaB homodimers and Egr-1.
    Kostadinova RM; Nawrocki AR; Frey FJ; Frey BM
    FASEB J; 2005 Apr; 19(6):650-2. PubMed ID: 15659537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-inflammatory cytokine induction of 11β-hydroxysteroid dehydrogenase type 1 in A549 cells requires phosphorylation of C/EBPβ at Thr235.
    Esteves CL; Verma M; Róg-Zielińska E; Kelly V; Sai S; Breton A; Donadeu FX; Seckl JR; Chapman KE
    PLoS One; 2013; 8(9):e75874. PubMed ID: 24086653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta.
    Sai S; Esteves CL; Kelly V; Michailidou Z; Anderson K; Coll AP; Nakagawa Y; Ohzeki T; Seckl JR; Chapman KE
    Mol Endocrinol; 2008 Sep; 22(9):2049-60. PubMed ID: 18617597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
    Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K
    Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
    Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid reamplification within cells intensifies NF-kappaB and MAPK signaling and reinforces inflammation in activated preadipocytes.
    Ishii-Yonemoto T; Masuzaki H; Yasue S; Okada S; Kozuka C; Tanaka T; Noguchi M; Tomita T; Fujikura J; Yamamoto Y; Ebihara K; Hosoda K; Nakao K
    Am J Physiol Endocrinol Metab; 2010 May; 298(5):E930-40. PubMed ID: 19776225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumour necrosis factor-alpha-mediated suppression of the CCAAT/enhancer binding protein-alpha gene transcription in hepatocytes involves inhibition of autoregulation.
    Foka P; Singh NN; Salter RC; Ramji DP
    Int J Biochem Cell Biol; 2009 May; 41(5):1189-97. PubMed ID: 19027873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta.
    Kagan BL; Henke RT; Cabal-Manzano R; Stoica GE; Nguyen Q; Wellstein A; Riegel AT
    Cancer Res; 2003 Apr; 63(7):1696-705. PubMed ID: 12670924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of adipocyte 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) by CCAAT/enhancer-binding protein (C/EBP) β isoforms, LIP and LAP.
    Esteves CL; Kelly V; Bégay V; Man TY; Morton NM; Leutz A; Seckl JR; Chapman KE
    PLoS One; 2012; 7(5):e37953. PubMed ID: 22662254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceramide and adenosine 5'-monophosphate-activated protein kinase are two novel regulators of 11beta-hydroxysteroid dehydrogenase type 1 expression and activity in cultured preadipocytes.
    Arai N; Masuzaki H; Tanaka T; Ishii T; Yasue S; Kobayashi N; Tomita T; Noguchi M; Kusakabe T; Fujikura J; Ebihara K; Hirata M; Hosoda K; Hayashi T; Sawai H; Minokoshi Y; Nakao K
    Endocrinology; 2007 Nov; 148(11):5268-77. PubMed ID: 17702848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of 11beta-hydroxysteroid dehydrogenase type 1 with RNA interference substantially attenuates 3T3-L1 adipogenesis.
    Liu Y; Park F; Pietrusz JL; Jia G; Singh RJ; Netzel BC; Liang M
    Physiol Genomics; 2008 Feb; 32(3):343-51. PubMed ID: 18073273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of 11beta-hydroxysteroid dehydrogenase type-1 and -2 gene transcription by proinflammatory cytokines in vascular smooth muscle cells.
    Tsugita M; Iwasaki Y; Nishiyama M; Taguchi T; Shinahara M; Taniguchi Y; Kambayashi M; Terada Y; Hashimoto K
    Life Sci; 2008 Sep; 83(11-12):426-32. PubMed ID: 18692075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization and glucocorticoid regulation of 11beta-hydroxysteroid dehydrogenase type 1 mRNA in the male mouse forebrain.
    Pelletier G; Luu-The V; Li S; Bujold G; Labrie F
    Neuroscience; 2007 Mar; 145(1):110-5. PubMed ID: 17207581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 mRNA and glucocorticoid receptor protein during mouse embryonic development.
    Thompson A; Han VK; Yang K
    J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):367-75. PubMed ID: 15145446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of hepatic lipase expression by elevation of cAMP in human hepatoma but not adrenocortical cells.
    van Deursen D; Botma GJ; Jansen H; Verhoeven AJ
    Mol Cell Endocrinol; 2008 Nov; 294(1-2):37-44. PubMed ID: 18675312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of alternative promoter usage in expression of HSD11B1 including the development of a transcript-specific quantitative real-time PCR method.
    Staab CA; Stegk JP; Haenisch S; Neiss E; Köbsch K; Ebert B; Cascorbi I; Maser E
    Chem Biol Interact; 2011 May; 191(1-3):104-12. PubMed ID: 21215738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.